Bristol-Myers Squibb Co - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
BMY New York 2834 https://www.bms.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bristol-Myers Squibb Co

J&J Files Application for Darzalex Label Expansion in Europe - Mar 25th, 2019 9:13 am
Report: Developing Opportunities within Bristol-Myers Squibb, AutoNation, FirstEnergy, Charles River Laboratories International, Yum! Brands, and AGNC Investment — Future Expectations, Projections Moving into 2019 - Mar 25th, 2019 5:40 am
Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders Highlighting the Compelling Strategic and Financial Rationale of the Celgene Transaction; Company Provides Additional Investor Materials - Mar 25th, 2019 4:59 am
Is It Safe to Buy Biogen Stock Right Now? - Mar 24th, 2019 11:00 am
Why Bristol-Myers Squibb (BMY) is a Great Dividend Stock Right Now - Mar 22nd, 2019 7:15 am
Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market - Mar 21st, 2019 8:10 am
Bristol-Myers' Celgene Buyout Still Uncertain Amid Opposition - Mar 21st, 2019 8:03 am
Proxy Advisors Could Tilt the Scales in the Bristol-Celgene Deal. Watch for Their Calls Next Week. - Mar 21st, 2019 5:30 am
Bristol-Myers Squibb (BMY) Dips More Than Broader Markets: What You Should Know - Mar 20th, 2019 3:45 pm
Pfizer/Merck KGaA End Bavencio+Talzenna Ovarian Cancer Study - Mar 20th, 2019 9:30 am
Starboard vs. Bristol-Myers Squibb: Who'll Win This Brewing Battle? - Mar 19th, 2019 7:33 pm
Analysts Have Revised BMY’s Target Price Downward in March - Mar 19th, 2019 1:17 pm
Starboard Is Against the Bristol-Myers and Celgene Deal. Now It Gets Interesting. - Mar 19th, 2019 12:17 pm
Bristol-Myers Pushes Celgene Deal, Starboard Hits Back, in $74B Takeover Spat - Mar 19th, 2019 11:14 am
Roche's Tecentriq Gets FDA Approval for Difficult Lung Cancer - Mar 19th, 2019 9:56 am
Jim Cramer Breaks Down Tilray Earnings, Elon Musk's Twitter and Bristol-Myers - Mar 19th, 2019 7:53 am
Bristol-Myers Squibb and Starboard Value square off over Celgene deal - Mar 19th, 2019 7:45 am
Large-Cap Pharmaceuticals Industry Outlook: A Recovery Ahead? - Mar 19th, 2019 6:40 am
Starboard Issues Investor Presentation Opposing Bristol-Myers Squibb's Ill-Advised Proposed Acquisition of Celgene - Mar 19th, 2019 5:00 am
Bristol-Myers Squibb Files Investor Presentation Highlighting Significant Benefits of Pending Transaction with Celgene - Mar 19th, 2019 4:59 am